XML 79 R34.htm IDEA: XBRL DOCUMENT v3.20.1
Revenues, Recognition and Allowances (Tables)
 12 Months Ended
Dec. 31, 2019
Revenue from Contract with Customer [Abstract]  
Disaggregation of Revenues Net Sales (in thousands) for the three years ended December 31, 2019 and 2018 were as follows (prior-period amounts are not adjusted under the modified-retrospective method of adoption):
Years ended December 31,
20192018
Company product sales$64,291  $59,591  
Contract manufacturing sales1,362  6,047  
Research and development services and other income243  227  
Revenue, net$65,896  $65,865  
Disaggregated information for the Company product sales revenue has been recognized in the accompanying audited Consolidated Statements of Operations, and is presented below according to contract type (in thousands):



Years ended December 31,
Company Product Sales20192018
Topical$46,150  $35,118  
Injectables18,141  24,473  
Total$64,291  $59,591  
Schedule Of Annual Activity Allowance For Customer Deductions Disclosure
The Company's adjustments for the deductions to gross product sales for the two years ended December 31, 2019 and 2018 are as follows (in thousands):
 Years ended December 31,
 20192018
Gross product sales$156,301  $158,278  
Reduction to gross product sales:  
Chargebacks and billbacks60,008  60,770  
Wholesaler fees for service9,000  5,503  
Sales discounts and other allowances23,002  32,414  
Total reduction to gross product sales$92,010  $98,687  
Total product sales, net$64,291  $59,591